Ashlyn's Shared Resources

Empagliflozin Reduces Risk of Cardiovascular Events in Heart Failure With Preserved Ejection Fraction
A double-blind trial was conducted to assess the effects of empagliflozin in patients with heart failure and preserved ejection fraction....

Empagliflozin Lowers Cardiovascular Death and Mortality in High-Risk Patients With Type 2 Diabetes
Researchers of a large, randomized trial evaluated the cardiovascular effects of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, in patients...

Diabetes Treatment Guidelines for Older Adults: Tailoring Care Based on Health, Aging, and Comorbidities
This guideline provides clinical practice guidance for treating diabetes in older adults, particularly those over the age of 65, as...

Expanding CGM Use in Diabetes: Standardized Metrics, Personalized Goals, and A1C Complementation
The adoption of continuous glucose monitoring (CGM) is growing among both type 1 and type 2 diabetes populations, but its...

Updated Hypoglycemia Guidelines: Key Recommendations on CGM, Insulin, Education, and Prevention
Hypoglycemia is a common concern for people with diabetes, especially those using insulin and sulfonylureas, as these medications increase the...

ADA Updates Standards: Expanded CGM Use, Personalized Care, and Improved Access
The American Diabetes Association (ADA) has updated its standards of care to reflect the growing role of diabetes technology in...